Rate My Professor Safina Gadeock

Gadeock's work leverages organoid models to simulate mucosal healing processes in IBD, paving the way for personalized therapeutic screening. Notable publications include "Type I interferons in inflammatory bowel diseases: balancing barrier integrity, repair and inflammation in the intestinal epithelium" (Frontiers in Medicine, 2025, co-authored with M.R. King and R.A. Kemp); "An autologous colonic organoid-derived monolayer model to study immune:bacterial interactions in Crohn's disease patients" (Clinical & Translational Immunology, 2022, co-authored with H.C.K. Angus, P.C.M. Urbano, and others); "Assessment of source material for human intestinal organoid culture for research and clinical use" (BMC Research Notes, 2022, co-authored with P.C.M. Urbano, H.C.K. Angus, and others); and "Sprouty2 limits intestinal tuft and goblet cell numbers through GSK3β-mediated restriction of epithelial IL-33" (Nature Communications, 2021). She advises research for MICR 360, BBiomedSc, BSc(Hons), PhD students, medical resident fellows, and postdoctoral fellows. Professional memberships encompass the New Zealand Society of Gastroenterology (since 2015), Gut Health Network, Live Human Tissue Network, Maurice Wilkins Centre, Australian Society of Immunology, and American Gastroenterological Association.